Huntington National Bank’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.6M Buy
48,620
+748
+2% +$256K 0.09% 169
2026
Q1
$16.8M Buy
47,872
+6,180
+15% +$2.2M 0.09% 169
2025
Q4
$13.6M Sell
41,692
-1,417
-3% -$449K 0.08% 166
2025
Q3
$12.2M Sell
43,109
-984
-2% -$285K 0.07% 178
2025
Q2
$12.3M Sell
44,093
-961
-2% -$272K 0.08% 170
2025
Q1
$14M Sell
45,054
-5,078
-10% -$1.5M 0.1% 156
2024
Q4
$13.1M Buy
50,132
+1,095
+2% +$325K 0.09% 160
2024
Q3
$15.8M Sell
49,037
-301
-0.6% -$98.5K 0.11% 153
2024
Q2
$15.4M Buy
49,338
+202
+0.4% +$59.3K 0.12% 156
2024
Q1
$14M Sell
49,136
-2,793
-5% -$817K 0.11% 161
2023
Q4
$15M Sell
51,929
-688
-1% -$187K 0.14% 151
2023
Q3
$14.1M Sell
52,617
-1,236
-2% -$308K 0.14% 149
2023
Q2
$12M Sell
53,853
-4,386
-8% -$1.02M 0.11% 168
2023
Q1
$14.1M Sell
58,239
-9,804
-14% -$2.41M 0.14% 151
2022
Q4
$17.9M Sell
68,043
-5,547
-8% -$1.49M 0.19% 124
2022
Q3
$16.6M Sell
73,590
-3,887
-5% -$942K 0.19% 122
2022
Q2
$18.8M Sell
77,477
-1,029
-1% -$252K 0.2% 122
2022
Q1
$19M Sell
78,506
-3,066
-4% -$704K 0.18% 124
2021
Q4
$18.4M Sell
81,572
-6,551
-7% -$1.38M 0.17% 130
2021
Q3
$18.7M Sell
88,123
-3,178
-3% -$731K 0.19% 126
2021
Q2
$22.3M Buy
91,301
+10,651
+13% +$2.62M 0.22% 112
2021
Q1
$20.1M Sell
80,650
-3,749
-4% -$895K 0.24% 110
2020
Q4
$19.4M Sell
84,399
-9,264
-10% -$2.14M 0.25% 102
2020
Q3
$23.8M Sell
93,663
-1,719
-2% -$426K 0.35% 85
2020
Q2
$22.5M Sell
95,382
-3,433
-3% -$783K 0.36% 82
2020
Q1
$20M Sell
98,815
-3,636
-4% -$794K 0.38% 80
2019
Q4
$24.7M Sell
102,451
-1,586
-2% -$350K 0.37% 85
2019
Q3
$20.1M Sell
104,037
-10,443
-9% -$2M 0.32% 93
2019
Q2
$21.1M Sell
114,480
-11,733
-9% -$2.1M 0.34% 90
2019
Q1
$24M Sell
126,213
-8,655
-6% -$1.65M 0.4% 80
2018
Q4
$26.3M Sell
134,868
-8,180
-6% -$1.6M 0.47% 68
2018
Q3
$29.7M Sell
143,048
-14,877
-9% -$2.93M 0.46% 70
2018
Q2
$29.2M Sell
157,925
-26,331
-14% -$4.66M 0.48% 64
2018
Q1
$31.4M Sell
184,256
-33,968
-16% -$6.24M 0.52% 60
2017
Q4
$37.9M Sell
218,224
-32,582
-13% -$5.77M 0.61% 48
2017
Q3
$46.8M Sell
250,806
-248
-0.1% -$43.9K 0.79% 29
2017
Q2
$43.2M Buy
251,054
+3,090
+1% +$503K 0.76% 33
2017
Q1
$40.7M Buy
247,964
+3,464
+1% +$576K 0.72% 35
2016
Q4
$35.7M Buy
244,500
+21,270
+10% +$3.2M 0.65% 45
2016
Q3
$37.2M Buy
223,230
+35,327
+19% +$5.97M 0.69% 38
2016
Q2
$28.6M Buy
187,903
+51,021
+37% +$7.93M 0.71% 37
2016
Q1
$21.9M Sell
136,882
-30,005
-18% -$4.46M 0.53% 59
2015
Q4
$27.1M Buy
166,887
+12,376
+8% +$1.95M 0.69% 35
2015
Q3
$21.4M Buy
154,511
+9,293
+6% +$1.46M 0.56% 50
2015
Q2
$22.3M Buy
145,218
+8,251
+6% +$1.32M 0.54% 58
2015
Q1
$21.9M Buy
136,967
+10,023
+8% +$1.58M 0.53% 58
2014
Q4
$20.2M Buy
126,944
+8,992
+8% +$1.4M 0.48% 67
2014
Q3
$16.6M Buy
117,952
+26,548
+29% +$3.47M 0.34% 87
2014
Q2
$10.8M Sell
91,404
-12,082
-12% -$1.4M 0.21% 122
2014
Q1
$12.8M Buy
103,486
+16,362
+19% +$1.98M 0.25% 103
2013
Q4
$9.94M Buy
87,124
+9,520
+12% +$1.08M 0.26% 112
2013
Q3
$8.69M Buy
77,604
+3,027
+4% +$328K 0.26% 111
2013
Q2
$7.36M Buy
+74,577
New +$7.74M 0.23% 119

Other funds holding AMGN

Huntington National Bank's AMGN Position: Q2 2026 in Review

Huntington National Bank increased its Amgen (AMGN) stake by 1.6% in Q2 2026, buying an estimated $256K and bringing the position to 48,620 shares worth $17.6M. The position accounts for 0.09% of the portfolio, ranked #169.

Huntington National Bank first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $46.8M in Q3 2017. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Huntington National Bank held 48,620 shares of Amgen worth $17.6M as of Q2 2026.
  • Huntington National Bank bought 748 Amgen shares in Q2 2026, an estimated $256K.
  • Amgen made up 0.09% of Huntington National Bank's portfolio in Q2 2026, its #169 holding.
  • Huntington National Bank first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • Huntington National Bank's Amgen position peaked at $46.8M in Q3 2017.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.